Product NDC: | 0069-0107 |
Proprietary Name: | Pamidronate Disodium |
Non Proprietary Name: | Pamidronate Disodium |
Active Ingredient(s): | 3 mg/mL & nbsp; Pamidronate Disodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0107 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078520 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110510 |
Package NDC: | 0069-0107-01 |
Package Description: | 10 mL in 1 VIAL (0069-0107-01) |
NDC Code | 0069-0107-01 |
Proprietary Name | Pamidronate Disodium |
Package Description | 10 mL in 1 VIAL (0069-0107-01) |
Product NDC | 0069-0107 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pamidronate Disodium |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110510 |
Marketing Category Name | ANDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | PAMIDRONATE DISODIUM |
Strength Number | 3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |